Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Neiss, D. Elkharrat, S. Kohno, J. A. Paladino, R. R. Reinert (Munich, Aachen, Germany; Paris, France; Nagasaki, Japan; Buffalo, United States Of America). Hospitalisation costs for community-acquired pneumonia (CAP) in France (F), Germany (D), Japan (J) and USA. Eur Respir J 2004; 24: Suppl. 48, 182

Member's Comments

No comment yet.

Related content which might interest you: The impact of antimicrobial resistance on the cost-effectiveness of empirical treatment of community-acquired pneumonia (CAP) in France (FR), Belgium (BE) and Germany (DE) Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Chronic alcoholics[scquote] (CA) knowledge (KN) and social stigmatisation (ST) regarding tuberculosis (TB) Source: Eur Respir J 2001; 18: Suppl. 33, 322s Year: 2001 Evolution of morbidity of respiratory diseases (RD) with temporary disability (TD) in St Petersburg, Russia, 1991-2001 Source: Eur Respir J 2003; 22: Suppl. 45, 113s Year: 2003 Incidence and etiology of early (E) and late (L) onset ventilator-associated pneumonia (VAP) in a university hospital Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Flu A(H1N1pdm09) and pneumonia: the burden of comorbidities (2009 vs 2019) Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019 Determination of community acquired pneumonia (CAP) severity in pregnant (pr.) Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 Management of community acquired pneumonia (CAP) in a UK district general hospital (DGH) Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Pulmonary Rehabilitation (PR) in Cheshire and Merseyside (C&M) Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 2 Year: 2020 Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 Drug sensitivity pattern (first line ATT) in DOTS failure & relapse cases (Cat I & Cat II) rntcp, India Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 Macrolides vs quinolones in Legionella pneumonia treatment: CAPAVANT group. Valencia (Spain) Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study) Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Lower overall healthcare costs with telithromycin (TEL) versus clarithromycin (CLA) in community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 152s Year: 2003 Changes in drug prescription for asthma (A) and COPD (C) by GPs in Italy Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010 Association between air pollution and hospitalizations for bronchiectasis in Badalona (Barcelona), Spain (2007-2015) Source: International Congress 2017 – Lung function, respiratory symptoms and obstructive sleep apnoea Year: 2017 Are we missing asthma COPD overlap (ACO) diagnosis among patient with COPD?Alameeri Amel(1), Dudina Alexandra(1) , Stephen Lane(1), Kennedy Merian(2) Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Evolution of respiratory morbidity (RD) in Sankt-Petersburg, Russia, between 1991 and 2000 Source: Eur Respir J 2002; 20: Suppl. 38, 515s Year: 2002 Resistance of problematic gram(-) respiratory pathogens selected from in-patients (Yaroslavl, Russia, 2011) Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Evolution of mortality from respiratory diseases (RD) in Sankt-Petersburg, Russia, between 1991 and 2000 Source: Eur Respir J 2002; 20: Suppl. 38, 515s Year: 2002